GlassScriptPhysician profile
Sarah Cook
NPI 1649623265
$2,118.42
in general payments reported to CMS, 2019-2025
30 companies · $762 in 2025
The $762 reported for 2025 was more than what 75% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $180 · 2022: $25.22 · 2023: $579 · 2024: $573 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,814 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,813.69 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $256.24 | 2024-2025 | Veozah |
| Daiichi Sankyo INC. | $210.79 | 2023-2025 | Injectafer, Vanflyta |
| Exeltis, USA INC. | $176.17 | 2023-2025 | Slynd |
| Sage Therapeutics, LLC | $160.16 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $143.81 | 2021-2024 | |
| Janssen Scientific Affairs, LLC | $137.85 | 2023 | Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $135.14 | 2021-2024 | Xifaxan, Trulance |
| Pfizer INC. | $133.65 | 2022-2025 | |
| Shield Therapeutics INC | $117.19 | 2023-2025 | Accrufer |
| Mayne Pharma Commercial LLC | $115.50 | 2024-2025 | |
| Exact Sciences Corporation | $56.12 | 2024-2025 | Cologuard Collection Kit |
| Kedrion Biopharma, INC. | $37.64 | 2023 | Gammaked, Koate, Kedrab |
| Amgen INC. | $35.02 | 2024-2025 | Evenity, Prolia, Prolia |
| Regeneron Healthcare Solutions, INC. | $33.57 | 2025 | Dupixent |
| Genzyme Corporation | $32.56 | 2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $30.57 | 2023 | Stelara |
| Ardelyx, INC. | $29.97 | 2023 | Ibsrela |
| Radius Health, INC. | $27.47 | 2025 | Tymlos |
| Hologic Sales and Service, LLC | $27.41 | 2025 | Thinprep 2000 Processor, Aptima |
| Smith+Nephew, INC. | $26.85 | 2025 | Pico |
| Takeda Pharmaceuticals U.S.A., INC. | $23.04 | 2023 | Entyvio |
| Scpharmaceuticals INC. | $21.96 | 2023 | |
| Nestle Healthcare Nutrition INC. | $21.01 | 2023 | |
| Ironwood Pharmaceuticals, INC | $20.68 | 2023 | Linzess |
| Supernus Pharmaceuticals, INC. | $19.89 | 2025 | Qelbree |
| Organon LLC | $19.01 | 2024 | |
| Glaxosmithkline, LLC. | $18.70 | 2024 | Trelegy Ellipta |
| Braintree Laboratories, INC. | $17.83 | 2021 | |
| Lilly USA, LLC | $16.95 | 2025 | Zepbound |
| Lundbeck LLC | $15.67 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.